Identification of Prominin‐2 as a new player of cardiomyocyte senescence in the aging heart
Aging Cell · 2024
DOI: 10.1111/acel.14204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2024. Verfasst von D Maggiorani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolic and Cardiovascular Diseases (I2MC), UMR-1297 INSERM, University of Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Cellular Senescence, Aging. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conseil Régional des Pays de la Loire, Fondation pour la Recherche Médicale, Agence Nationale de la Recherche.
Abstract (Originalsprache)
The aging heart is characterized by a number of structural changes leading to ventricular stiffness, impaired resistance to stress and increased risk of developing heart failure (HF). Genetic or pharmacological removal of senescent cells has recently demonstrated the possibility to relieve some cardiac aging features such as hypertrophy and fibrosis. However, the contribution of the different cell types in cardiac aging remains fragmentary due to a lack of cell‐specific markers. Cardiomyocytes undergo post‐mitotic senescence in response to telomere damage, characterized by persistent DNA damage response and expression of the classical senescence markers p21 and p16, which are shared by many other cell types. In the present study, we used transcriptomic approaches to discover new markers specific for cardiomyocyte senescence. We identified Prominin2 (Prom2), encoding a transmembrane glycoprotein, as the most upregulated gene in cardiomyocytes of aged mice compared to young mice. We showed that Prom2 was upregulated by a p53‐dependent pathway in stress‐induced premature senescence. Prom2 expression correlated with cardiomyocyte hypertrophy in the hearts of aged mice and was increased in atrial samples of patients with HF with preserved ejection fraction. Consistently, Prom2 overexpression was sufficient to drive senescence, hypertrophy and resistance to cytotoxic stress while Prom2 shRNA silencing inhibited these features in doxorubicin‐treated cardiac cells. In conclusion, we identified Prom2 as a new player of cardiac aging, linking cardiomyocyte hypertrophy to senescence. These results could provide a better understanding and targeting of cell‐type specific senescence in age‐associated cardiac diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Metabolic and Cardiovascular Diseases (I2MC), UMR-1297 INSERM, University of Toulouse, Toulouse, France.
- Rangueil Hospital, CHU, Toulouse, France.
- RESTORE Research Center, UMR-1301, INSERM, CNRS, EFS, University of Toulouse, Toulouse, France.
- Univ Angers, INSERM, CNRS, MITOVASC, Equipe MitoLab, SFR ICAT, Angers, France.
ORCID-Profile: A Parini
Förderung
- Conseil Régional des Pays de la Loire
- Fondation pour la Recherche Médicale
- Agence Nationale de la Recherche
- Fondation Lefoulon-Delalande
- Région Occitanie Pyrénées-Méditerranée
- Fédération Francaise de Cardiologie
Zitieren
APA
Maggiorani, D., Santin, Y., Formoso, K., Drapé, E., Martini, H., Brun, S., Cousin, G., Lairez, O., Lezoualc'h, F., Parini, A., Douin-Echinard, V., & Mialet-Perez, J. (2024). Identification of Prominin‐2 as a new player of cardiomyocyte senescence in the aging heart. Aging Cell. https://doi.org/10.1111/acel.14204
Vancouver
Maggiorani D, Santin Y, Formoso K, Drapé E, Martini H, Brun S, et al. Identification of Prominin‐2 as a new player of cardiomyocyte senescence in the aging heart. Aging Cell. 2024. doi:10.1111/acel.14204
BibTeX
@article{Maggiorani2024,
author = {Maggiorani, D and Santin, Y and Formoso, K and Drapé, E and Martini, H and Brun, S and Cousin, G and Lairez, O and Lezoualc'h, F and Parini, A and Douin-Echinard, V and Mialet-Perez, J},
title = {Identification of Prominin‐2 as a new player of cardiomyocyte senescence in the aging heart},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14204}
}
EUVIMED